Literature DB >> 33562540

Hypothalamic Inflammation as a Potential Pathophysiologic Basis for the Heterogeneity of Clinical, Hormonal, and Metabolic Presentation in PCOS.

Danai Barlampa1, Maria Sotiria Bompoula2, Alexandra Bargiota3, Sophia Kalantaridou2, George Mastorakos1, Georgios Valsamakis1,2,3.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age. It is a heterogeneous condition characterized by reproductive, endocrine, metabolic, and psychiatric abnormalities. More than one pathogenic mechanism is involved in its development. On the other hand, the hypothalamus plays a crucial role in many important functions of the body, including weight balance, food intake, and reproduction. A high-fat diet with a large amount of long-chain saturated fatty acids can induce inflammation in the hypothalamus. Hypothalamic neurons can sense extracellular glucose concentrations and participate, with a feedback mechanism, in the regulation of whole-body glucose homeostasis. When consumed nutrients are rich in fat and sugar, and these regulatory mechanisms can trigger inflammatory pathways resulting in hypothalamic inflammation. The latter has been correlated with metabolic diseases, obesity, and depression. In this review, we explore whether the pattern and the expansion of hypothalamic inflammation, as a result of a high-fat and -sugar diet, may contribute to the heterogeneity of the clinical, hormonal, and metabolic presentation in PCOS via pathophysiologic mechanisms affecting specific areas of the hypothalamus. These mechanisms could be potential targets for the development of effective therapies for the treatment of PCOS.

Entities:  

Keywords:  PCOS; high-fat diet; hypothalamic inflammation; hypothalamus; nutrients overconsumption; polycystic ovary syndrome

Year:  2021        PMID: 33562540      PMCID: PMC7915850          DOI: 10.3390/nu13020520

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  107 in total

Review 1.  Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases.

Authors:  Christian Hölscher
Journal:  J Endocrinol       Date:  2014-03-07       Impact factor: 4.286

Review 2.  Inflammation and metabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

Review 3.  CNS-targets in control of energy and glucose homeostasis.

Authors:  André Kleinridders; A Christine Könner; Jens C Brüning
Journal:  Curr Opin Pharmacol       Date:  2009-10-31       Impact factor: 5.547

4.  Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus.

Authors:  Philippe Ciofi; Maurice Garret; Olivier Lapirot; Pierrette Lafon; Anne Loyens; Vincent Prévot; Jon E Levine
Journal:  Endocrinology       Date:  2009-10-16       Impact factor: 4.736

5.  Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Iris Lee; Laura G Cooney; Shailly Saini; Mary D Sammel; Kelly C Allison; Anuja Dokras
Journal:  Eat Weight Disord       Date:  2018-06-26       Impact factor: 4.652

6.  Astrocytes control food intake by inhibiting AGRP neuron activity via adenosine A1 receptors.

Authors:  Liang Yang; Yong Qi; Yunlei Yang
Journal:  Cell Rep       Date:  2015-04-23       Impact factor: 9.423

7.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

Review 8.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

9.  New approach to polycystic ovary syndrome and other forms of anovulatory infertility.

Authors:  Joop S E Laven; Babak Imani; Marinus J C Eijkemans; Bart C J M Fauser
Journal:  Obstet Gynecol Surv       Date:  2002-11       Impact factor: 2.347

Review 10.  Energy balance and reproduction.

Authors:  Jill E Schneider
Journal:  Physiol Behav       Date:  2004-04
View more
  1 in total

1.  Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.

Authors:  Kehinde S Olaniyi; Stephanie E Areloegbe; Mosunmola B Oyeleke
Journal:  Endocrine       Date:  2022-09-16       Impact factor: 3.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.